Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Non Operating Income (2020 - 2025)

Journey Medical's Non Operating Income history spans 6 years, with the latest figure at -$804000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income fell 23.31% year-over-year to -$804000.0, compared with a TTM value of -$3.2 million through Dec 2025, down 242.51%, and an annual FY2025 reading of -$3.2 million, down 242.51% over the prior year.
  • Non Operating Income for Q4 2025 was -$804000.0 at Journey Medical, down from -$786000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $504000.0 in Q3 2024, with the low at -$4.4 million in Q4 2021.
  • Average Non Operating Income over 5 years is -$760950.0, with a median of -$606000.0 recorded in 2022.
  • Year-over-year, Non Operating Income plummeted 2016.02% in 2021 and then soared 239.61% in 2024.
  • Tracing DERM's Non Operating Income over 5 years: stood at -$4.4 million in 2021, then soared by 85.46% to -$634000.0 in 2022, then soared by 113.72% to $87000.0 in 2023, then plummeted by 849.43% to -$652000.0 in 2024, then fell by 23.31% to -$804000.0 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Non Operating Income are -$804000.0 (Q4 2025), -$786000.0 (Q3 2025), and -$860000.0 (Q2 2025).